Improving access to HPV vaccines for young girls in Nigeria
Research Project 1
This study is all about helping young girls in Nigeria get the HPV vaccine, which can protect them from certain cancers, by finding out what’s stopping them from getting it and working together with young people to come up with better ways to make the vaccine more accessible and raise awareness in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10931747 on NIH RePORTER |
What this research studies
This research aims to address the barriers preventing young girls in Nigeria from accessing HPV vaccination, which is crucial for preventing HPV-associated cancers. By employing a youth participatory action research framework, the project will actively involve young people in creating solutions to improve vaccine uptake. The approach includes decentralizing vaccine access and utilizing local resources to enhance awareness and support within communities. The project will also implement innovative tools and participatory methods to engage youth and increase their involvement in health initiatives.
Who could benefit from this research
Good fit: Ideal candidates for this research are girls aged 9-15 years old living in Nigeria.
Not a fit: Patients outside the age range of 9-15 years or those not residing in Nigeria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of HPV-associated cancers among young girls in Nigeria.
How similar studies have performed: Previous research has shown success in similar community-based approaches to increase vaccination rates, indicating potential for positive outcomes in this project.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.